SB 202190 100 mg | 99.55%
TargetMol
SB 202190 is a selective and cell-permeable inhibitor of p38 MAPK (IC50s: 50/100 nM for p38α/p38β).
More Information Supplier PageSB 202190
Search Results
Proadifen hydrochloride 100 mg | 100.00%
TargetMol
Proadifen hydrochloride is an inhibitor of drug metabolism and cytochrome P-450 enzyme system activity.
More Information Supplier PageProadifen hydrochloride
CA-5f 50 mg | 99.83%
TargetMol
CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.
More Information Supplier PageCA-5f
CA-5f 25 mg | 99.83%
TargetMol
CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.
More Information Supplier PageCA-5f
CA-5f 10 mg | 99.83%
TargetMol
CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.
More Information Supplier PageCA-5f
CA-5f 5 mg | 99.83%
TargetMol
CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.
More Information Supplier PageCA-5f
Nestoron 100 mg | Purity Not Available
TargetMol
Nestoron, a synthetic progestin, is a high-affinity agonist of the progesterone receptor (EC50: 10.3 nM).
More Information Supplier PageNestoron
Fingolimod hydrochloride 200 mg | 99.29%
TargetMol
Fingolimod, a novel immune modulator, is a sphingosine 1-phosphate (S1P) antagonist (IC50: 0.033 nM in K562 and NK cells).
More Information Supplier PageFingolimod hydrochloride
Fingolimod hydrochloride 100 mg | 99.29%
TargetMol
Fingolimod, a novel immune modulator, is a sphingosine 1-phosphate (S1P) antagonist (IC50: 0.033 nM in K562 and NK cells).
More Information Supplier PageFingolimod hydrochloride
LY2109761 5 mg | 99.64%
TargetMol
LY2109761 is a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor with Ki of 38 nM and 300 nM, respectively; shown to negatively affect the phosphorylation of Smad2.
More Information Supplier PageLY2109761
